UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040641
Receipt number R000046386
Scientific Title Vonoprazan or Proton-pump inhibitor for gastric endoscopic submucosal dissection in patients under antithrombotic therapy: a randomized prospective multicenter study
Date of disclosure of the study information 2020/06/03
Last modified on 2023/12/11 18:43:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Vonoprazan or Proton-pump inhibitor for gastric endoscopic submucosal dissection in patients under antithrombotic therapy: a randomized prospective multicenter study

Acronym

V-POINT study

Scientific Title

Vonoprazan or Proton-pump inhibitor for gastric endoscopic submucosal dissection in patients under antithrombotic therapy: a randomized prospective multicenter study

Scientific Title:Acronym

V-POINT study

Region

Japan


Condition

Condition

gastric epithelial neoplasms

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to prospectively assess the superiority of vonoprazan over classical proton pump inhibitors regarding the risk of delayed bleeding after gastric endoscopic submucosal dissection in patients under antithrombotic therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of bleeding within 8 weeks after ESD.

Key secondary outcomes

1. Frequency of GERD-like symptoms after ESD.
2. Frequency of pain after ESD.
3. Healing of the ulcer at 8 weeks after ESD.
4. Adverse events related to ESD.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation


Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients will be randomly allocated to either VPZ or PPI group. In the PPI group, esomeprazole 20mg will be administered orally from the day before ESD to 54 days after ESD.

Interventions/Control_2

VPZ 20mg will be administered orally from the day before ESD to 54 days after ESD.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Gastric adenoma or early gastric cancer.
condition of early gastric cancer:
1) 2cm or smaller cT1a, well diff. UL0
2) larger than 2cm, cT1a, well diff.UL0
3) 3cm or smaller, cT1a, well diff. UL1
4) 2cm or smaller, cT1a, undiff. UL0
2. age 20 or older
3. PS=0,1,2
4. Laboratory data:
Hb 9g/dl or larger
Plt 100,000/mm3 or larger
AST, ALT 100 1U/l or less
PT-INR 80% or larger
5. Could be followed up for 56 days after ESD.
6. Those who gave written consent.

Key exclusion criteria

1. Those with simultaneous esophageal or duodenal endoscopic treatment.
2. Endoscopic treatment for upper digestive tract within 31 days before ESD.
3. Women with pregnancy,
4. Psychological disorders.
5. Presence of active infectious diseases.
6. Impossible to answer to F-Scale or VAS.
7. Allergy to VPZ or EPZ.

Target sample size

210


Research contact person

Name of lead principal investigator

1st name Kazuhiro
Middle name
Last name Furukawa

Organization

Nagoya University

Division name

Department of Gastroenterology & Hepatology, Nagoya University Graduate School of Medicine

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Japan

TEL

+81-52-744-2164

Email

kazufuru@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Naomi
Middle name
Last name Kakushima

Organization

Nagoya University

Division name

Department of Gastroenterology & Hepatology, Nagoya University Graduate School of Medicine

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Japan

TEL

+81-52-744-2164

Homepage URL


Email

n.kakushima@gmail.com


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

No funding source.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Graduate School of Medicine, IRB

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Japan

Tel

+81-052-744-2973

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

山下病院(愛知県)、名鉄病院(愛知県)、刈谷豊田総合病院(愛知県)、江南厚生病院(愛知県)、半田市立半田病院(愛知県)、名古屋第一赤十字病院(愛知県)、市立四日市病院(三重県)、静岡県立静岡がんセンター(静岡県)、石川県立中央病院(石川県)


Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

125

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 06 Month 03 Day

Date of IRB

2020 Year 08 Month 27 Day

Anticipated trial start date

2020 Year 09 Month 16 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 03 Day

Last modified on

2023 Year 12 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046386


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name